Article
Inhibition of thrombin by hirudin genetically fused to wild-type or mutant antithrombin.
Thrombosis research - 15 Dec 1996
Syed S, Kelly K E, Sheffield W P
Abstract excerpt
Recombinant fusion proteins consisting of hirudin variant 3 (HV3) fused at its C-terminus to either of two forms of mature rabbit antithrombin (AT) were generated in COS-I cells. HV3 fused to wild-type AT was designated HAT, while a similar chimeric protein in which the P12 residue of AT was mutated from Ala to Thr, was designated HAT(H) for the Hamilton (A382T) mutation. Addition of the HV3 domain resulted in a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.